Spruce

Developer of therapies for rare endocrine disorders

placeSan Francisco, California, United States calendar_todayFounded 2016 groups29 employees language sprucebio.com

Registered entities

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital571%
Other / undisclosed229%
Coming soon